Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients

被引：0
|
作者：
Varnado, S. [1 ]
Um, J. Y. [2 ]
Vongooru, H. [3 ]
Zolty, R. [3 ]
Lowes, B. D. [3 ]
Burdorf, A. [3 ]
Fenske, B. [1 ]
Huntsberry, A. [1 ]
Siddique, A. [2 ]
Moulton, M. J. [2 ]
Raichlin, E. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Cardiothorac Surg, Omaha, NE USA
[3] Univ Nebraska Med Ctr, Cardiol, Omaha, NE USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 04期
关键词：
D O I：
10.1016/j.healun.2016.01.554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
526
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [21] Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients
    Costanzo, MR
    Koch, DM
    Fisher, SG
    Heroux, AL
    Kao, WG
    Johnson, MR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (02): : 169 - 178
  • [22] Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy
    Shaddy, RE
    Revenaugh, JA
    Orsmond, GS
    Tani, LY
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (11): : 1370 - +
  • [23] Visfatin serum concentration is associated with cardiac allograft vasculopathy in heart transplant recipients
    Szczurek, Wioletta
    Gasior, Mariusz
    Skrzypek, Michal
    Szygula-Jurkiewicz, Bozena
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (10) : 2857 - 2866
  • [24] ASSESSMENT OF CARDIAC ALLOGRAFT VASCULOPATHY IN JAPANESE PEDIATRIC HEART TRANSPLANT RECIPIENTS.
    Kogaki, Shigetoyo
    Fukushima, Norihide
    Takahashi, Kunihiko
    Uchikawa, Toshiki
    Ishii, Ryo
    Higeno, Ryouta
    Ichimori, Hiroaki
    Okada, Yoko
    Ishida, Hidekazu
    Sawa, Yoshiki
    Ozono, Keiichi
    PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 317 - 317
  • [25] Percutaneous coronary interventions for cardiac allograft vasculopathy in pediatric heart transplant recipients
    Meena, N. K.
    Sachdeva, R.
    Frazier, E. A.
    Sachdeva, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 372 - 372
  • [26] Cardiac allograft vasculopathy: Differences in de novo and maintenance heart transplant recipients
    Frigerio, Maria
    Garascia, Andrea
    Roubina, Elena
    Distefano, Giada
    Orrego, Pedro Silva
    Colombo, Paola
    Bruschi, Giuseppe
    Vitali, Ettore
    TRANSPLANTATION, 2006, 82 (08) : S5 - S12
  • [27] The Effect of Medication Regimens on Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients
    Moffett, B. S.
    Hong, B. J.
    Denfield, S. W.
    Humlicek, T. J.
    Cabrera, A. G.
    Price, J. F.
    Dreyer, W. J.
    Jeewa, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S226 - S226
  • [28] Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients
    Birs, Antoinette S.
    Kao, Andrew S.
    Silver, Elizabeth
    Adler, Eric D.
    Taub, Pam R.
    Wilkinson, Michael J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2025, 19 (01) : 134 - 145
  • [29] OCT Assessment of Allograft Vasculopathy in Heart Transplant Recipients
    Hou, Jingbo
    Lv, Hang
    Jia, Haibo
    Zhang, Shuo
    Xing, Lei
    Liu, Haixia
    Kong, Junying
    Zhang, Shaosong
    Yu, Bo
    Jang, Ik-Kyung
    JACC-CARDIOVASCULAR IMAGING, 2012, 5 (06) : 662 - 663
  • [30] PLACENTA GROWTH FACTOR AS A MARKER OF CARDIAC ALLOGRAFT VASCULOPATHY SEVERITY IN HEART TRANSPLANT RECIPIENTS
    Shevchenko, Olga P.
    Orlova, Olga V.
    Mironkov, Boris L.
    Kazakov, Eduard N.
    Kormer, Arkady J.
    Shevchenko, Alex O.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 266 - 266
12345